Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer

被引:4
作者
Nakamura, Naoki [1 ]
Hojo, Hidehiro [1 ]
Inoue, Kazuya [2 ]
Hotta, Kenji [1 ]
Zenda, Sadamoto [1 ]
Baba, Hiromi [1 ]
Onozawa, Masakatsu [1 ]
Motegi, Atsushi [1 ]
Nakamura, Masaki [1 ]
Kibe, Yuichi [1 ]
Akimoto, Tetsuo [1 ]
机构
[1] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Takai Hosp, Dept Radiol, 470-8 Kuranosho, Tenri, Nara 6320006, Japan
关键词
lung cancer; radiation therapy; proton beam therapy; radiological change; STEREOTACTIC ABLATIVE RADIOTHERAPY; BODY RADIATION-THERAPY; MASS-LIKE CONSOLIDATION; INJURY; RECURRENCE; SBRT;
D O I
10.1093/jrr/rry028
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aimed to examine late radiological changes after proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) and to clarify correlations between mass-like radiological changes and patient characteristics. CT scans of patients who underwent passive scattering PBT for T1-2N0M0 NSCLC were analyzed retrospectively. Patients were considered eligible if follow-up CT was performed for at least 2 years, with no definite evidence of local recurrence. The following five periods were defined: (i) 6-12 months, (ii) 12-24 months, (iii) 24-36 months, (iv) 36-48 months and (v) 48-60 months after PBT. Late (>= 6 months) radiological changes were scored by consensus of three radiation oncologists according to classifications set forth by Koenig (Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 2002; 178: 1383-8.). CT scans of 113 patients (median follow-up, 36 months; range, 24-137 months) were evaluated. Late radiological changes during Periods (i), (ii), (iii), (iv) and (v) included modified conventional pattern (80%, 79%, 72%, 58% and 56%, respectively), mass-like changes (8%, 9%, 14%, 22% and 18%, respectively), scar-like changes (4%, 9%, 11%, 17% and 24%, respectively) and no increased density (8%, 3%, 3%, 2% and 2%, respectively). Mass-like changes were observed in 23 patients (20%). Among patients who developed mass-like changes, the median interval between the initiation of PBT and the onset of mass-like changes was 19 months (range, 6-62 months). In multivariate analysis, a peripheral location was found to be a significant factor (P = 0.035; odds ratio: 4.44; 95% confidence interval: 1.12-21.28). In conclusion, mass-like changes were observed in 20% of patients who underwent PBT. Patients with peripheral tumors showed a higher incidence of mass-like changes.
引用
收藏
页码:456 / 461
页数:6
相关论文
共 14 条
  • [1] Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non-Small-Cell Lung Cancer What We Have Learned
    Chang, Joe Y.
    Bezjak, Andrea
    Mornex, Francoise
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 577 - 585
  • [2] Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer
    Dahele, Max
    Palma, David
    Lagerwaard, Frank
    Slotman, Ben
    Senan, Suresh
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1221 - 1228
  • [3] Computed Tomography-Based Anatomic Assessment Overestimates Local Tumor Recurrence in Patients With Mass-like Consolidation After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
    Dunlap, Neal E.
    Yang, Wensha
    McIntosh, Alyson
    Sheng, Ke
    Benedict, Stanley H.
    Read, Paul W.
    Larner, James M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05): : 1071 - 1077
  • [4] A PILOT TRIAL OF SERIAL 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH MEDICALLY INOPERABLE STAGE I NON-SMALL-CELL LUNG CANCER TREATED WITH HYPOFRACTIONATED STEREOTACTIC BODY RADIOTHERAPY
    Henderson, Mark A.
    Hoopes, David J.
    Fletcher, James W.
    Lin, Pei-Fen
    Tann, Mark
    Yiannoutsos, Constantin T.
    Williams, Mark D.
    Fakiris, Achilles J.
    McGarry, Ronald C.
    Timmerman, Robert D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 789 - 795
  • [5] Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature
    Huang, Kitty
    Dahele, Max
    Senan, Suresh
    Guckenberger, Matthias
    Rodrigues, George B.
    Ward, Aaron
    Boldt, R. Gabriel
    Palma, David A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 102 (03) : 335 - 342
  • [6] CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers?
    Kimura, Tomoki
    Matsuura, Kanji
    Murakami, Yuji
    Hashimoto, Yasutoshi
    Kenjo, Masahiro
    Kaneyasu, Yuko
    Wadasaki, Koichi
    Hirokawa, Yutaka
    Ito, Katsuhide
    Okawa, Motoomi
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (02): : 483 - 491
  • [7] Radiation injury of the lung after three-dimensional conformal radiation therapy
    Koenig, TR
    Munden, RF
    Erasmus, JJ
    Sabloff, BS
    Gladish, GW
    Komaki, R
    Stevens, CW
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 178 (06) : 1383 - 1388
  • [8] Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J. A.
    Slotman, Ben J.
    Paul, Marinus A.
    Smit, Egbert F.
    Senan, Suresh
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 348 - 353
  • [9] Matsuo Y, 2007, INT J CLIN ONCOL, V12, P356, DOI 10.1007/s10147-007-0691-9
  • [10] High-dose proton beam therapy for stage I non-small-cell lung cancer
    Nihei, K
    Ogino, T
    Ishikura, S
    Nishimura, H
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01): : 107 - 111